Global GAS Pharyngitis Diagnostics Market Size By Product (Rapid Test Kit, Culture Test, PCR-Based Test), By End-User (Hospitals, Physician Clinics, Diagnostic Laboratories), By Geographic Scope And Forecast

GAS Pharyngitis Diagnostics Market Size And Forecast

GAS Pharyngitis Diagnostics Market size was valued at USD 170.60 Million in 2020 and is projected to reach USD 206.15 Million by 2028, growing at a CAGR of 2.4% from 2021 to 2028.

An increase in the number of patients led to drive demand for diagnosis and therefore demand for GAS Pharyngitis Diagnostics activity has increased. Also increasing government support in research activities and the healthcare sector will drive the market for GAS Pharyngitis Diagnostics. The Global GAS Pharyngitis Diagnostics Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global GAS Pharyngitis Diagnostics Market Definition

Sore throat, fever over 100.4°F, tonsillar exudates, and cervical adenopathy are all common signs and symptoms of streptococcal pharyngitis. With viral pharyngitis, coughing, coryza, and dysentery are more likely. The available testing kits for diagnosis are a throat culture and fast antigen detection tests. In recent years, GAS pharyngitis diagnostics have gotten a lot of attention The standard test for it is a throat culture. GAS pharyngitis diagnostics are undergoing continuous study and improvement in order to increase diagnostic accuracy. Rapid antigen detection testing has also increased greatly in terms of sensitivity and specificity.

According to National Center for Biotechnology Information. (NCBI), For adults and children, sore throats and pharyngitis account for more than 2% and 5% of all outpatient primary care visits, respectively. Inflammation of the pharynx, nasopharynx and tonsillar tissues characterizes this condition. The season of occurrence peaks in late winter and early spring. Viral infections account for 80% of cases, with bacterial and fungal infections accounting for the remaining 20%. For Canadian family physicians, we present an updated clinical overview of pharyngitis.

With 97 percent to 100 percent specificity20 and 90 percent to 95 percent sensitivity, throat culture remains the gold standard for bacterial pharyngitis diagnosis. Sadly, the cultivation of throat samples is challenging and can cause medications to be delayed. Antibiotic selection is rarely influenced by cultures, as current prescribing guidelines account for GAS. Rather, they can rule out atypical infections that require different antibiotic regimens, such as non-GAS and fungal pharyngitis. Identical diagnostics are possible with rapid antigen detection testing.

Using dipsticks, these point-of-care tests detect bacterial and viral antigens from tonsillar exudates or the posterior oropharynx. They are currently used to rule out streptococcal infections, respiratory syncytial virus infections, and influenza. RADT has a wide range of specificity and sensitivity, ranging from 54 percent to 100 percent for specificity and 38 percent to 100 percent for sensitivity, respectively Even though the fact the findings are fast, each kit is pathogen-specific and cannot distinguish between viral and bacterial pharyngitis. As a consequence, negative outcomes do not rule out the possibility of non-GAS bacterial pharyngitis.

Global GAS Pharyngitis Diagnostics Market Overview

The market is expected to develop due to an increase in the number of deaths caused by rheumatic heart disease, particularly in industrialized regions. Red infection and throat infections are caused by bacteria belonging to the group A streptococcus family. The GAS Pharyngitis Diagnostics Market is also expected to benefit from significant grassroots activity in the diagnostics business, as well as an influx of foreign direct investments and strong government initiatives. Rising consumer awareness of new-age diagnostic techniques that have been launched but are still in the design and development phase, combined with a consumer shift away from traditional healthcare mechanisms, is expected to provide the much-needed impetus for the GAS Pharyngitis Diagnostics Market to grow.

Due to a slew of obstacles connected with diagnosing GA pharyngitis, the market is anticipated to be impeded. The most important of these is to provide exact, appropriate, and rapid diagnostic results. Furthermore, market penetration may be hampered by a lack of awareness of recently established diagnostic tools, as well as a wide range of misconceptions reported in third-world economies and regions with erratic politico-legal dynamics. Due to a shift in the overall healthcare infrastructure to combat COVID-19 and its impacts, new diagnostic product introductions have been delayed, and clinical trials have been cancelled.

This could stifle the current market for the GAS Pharyngitis Diagnostics Market. Opportunity- Due to a major large number of recent cases of GAS pharyngitis recorded in the region, as well as a policy shift toward speedy creation and development of new-age therapeutic or diagnostic mechanisms, North America is expected to dominate the GAS Pharyngitis Diagnostics Market. According to (NCBI), The conventional approach for identifying pharyngitis caused by M. pneumoniae or C. pneumonia is serologic testing of acute and convalescent serum samples; however, PCR and culture are utilized generally in addition to serology for research purposes.

Serology can also establish the diagnosis of primary EBV infection, either through a heterophil antibody test (monospot) or the identification of immunoglobulin M (IgM) antibodies to the EBV viral capsid antigen in an acute serum sample. Although 85 percent of adolescents and adults acquire heterophil antibodies within a week of becoming unwell, children, especially those under the age of four, require specific EBV serology to be diagnosed. The viral cultivation of a nasopharyngeal sample or molecular detection methods such as PCR or RT-PCR can be used to identify common respiratory viruses that cause pharyngitis. The Infectious Disease Society of America and the American Academy of Pediatrics’ Committee on Infectious Diseases suggest confirming GAS infection by fast antigen detection tests, throat culture, or both.

Global GAS Pharyngitis Diagnostics MarketSegmentation Analysis

The Global GAS Pharyngitis Diagnostics Market is segmented on the basis of Product, End-User, And Geography.

GAS Pharyngitis Diagnostics Market, By Product

• Rapid Test Kit• Culture Test• PCR-Based Test

Based on Product, The market is bifurcated into Rapid Test Kit, Culture Test, and PCR-Based Test. For patients with acute pharyngitis, rapid antigen testing to diagnose group A Streptococcal (GAS) infection gives critical information for antibiotic decision-making. The importance of these decisions is shown by the fact that pharyngitis accounts for nearly 13 million office visits in the United States each year. Suppurative or non-suppurative consequences can occur in patients with GAS pharyngitis. Because chronic rheumatic fever was so important in the 1950s, preventing acute rheumatic fever became the main emphasis of pharyngitis treatment. While the prevalence of acute rheumatic fever has reduced, treating GAS infections in patients with acute pharyngitis remains the priority to reduce suppurative consequences, person-to-person dissemination, and symptom duration.

GAS Pharyngitis Diagnostics Market, By End-User

• Hospitals• Physician Clinics• Diagnostic Laboratories

Based on End-User, The market is bifurcated into Hospitals, Physician Clinics, and Diagnostic Laboratories. In hospitals, Rapid antigen detection tests should be used only when antibiotic initiation is a problem. Antibiotic beginning for pharyngitis should be done with caution since it does not prolong healing or raise the risk of S pyogenes infections. For adults and children, sore throats and pharyngitis account for more than 2% and 5% of all outpatient primary care visits, respectively. Inflammation of the pharynx, nasopharynx and tonsillar tissues characterizes this condition. The season of occurrence peaks in late winter and early spring. Viral infections account for 80% of cases, with bacterial and fungal infections accounting for the remaining 20%.

GAS Pharyngitis Diagnostics Market, By Geography

• North America• Europe• Asia Pacific• Rest of the world

On the basis of Regional Analysis, The Global GAS Pharyngitis Diagnostics Market is classified into North America, Europe, Asia Pacific, and Rest of the world. The Asia Pacific region is expected to witness the highest CAGR during the forecast period. This is primarily due to The bacterial infection Group A streptococcus (GAS) pharyngitis, generally known as strep throat, affects the back of the throat, including the tonsils. It is more common in young newborns and the elderly, and it happens mostly near the end of the winter season.

Fever, sore throat, abdominal ache, nausea, vomiting, red eyes, and diarrhoea are all common signs of the infection. Strep throat is a contagious disease spread through contact with an infected individual. As a result, high-traffic areas such as schools and military academies are expected to see the most transmission. A throat culture with increased sensitivity and a rapid strep test, which has the advantage of speedy results, is part of the standard diagnostic.

Key Players

The “Global GAS Pharyngitis Diagnostics Market” study report will provide a valuable insight with an emphasis on the global market including some of the major players such as Abbott Laboratories, Quidel Corporation, BD, Hoffmann-La Roche Ltd, BioMérieux SA, Beckman Coulter, Inc., Meridian Bioscience, Inc., Sekisui Diagnostics, and DiaSorin S.p.A. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• April 23, 2021, Quidel Corporation, a leading supplier of quick diagnostic testing solutions, cellular-based virology assays, and molecular diagnostic systems, confirmed recently that a distribution and fulfillment agreement with McKesson Corporation, a global leader in healthcare supply chain management solutions, has been completed.

• 18 Oct 2021, Roche, a Swiss healthcare business, has teamed up with PathAI to develop artificial intelligence (AI)-powered pathology technology solutions.

• Mar 16, 2021, In an all-cash agreement, Roche has agreed to purchase GenMark Diagnostics, a provider of molecular diagnostic solutions based in the United States, for $24.05 per share, or nearly $1.8 billion.

• 26 MAY 2021, The Beckman Coulter company has introduced a new microbioreactor with greater automation.

• Aug. 1, 2018, The DxM MicroScan WalkAway system, a diagnostic tool for bacterial identification and antibiotic susceptibility testing for microbiology laboratories, was commercialized today by Beckman Coulter.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.